Rockin Robin SongFlying The Web For News.
RobinPost Logo Amazon Prime Deals





Science Daily Reports

Boston Scientific anticipates that assisting in commercialising Siemens Healthineers’ 4D ICE catheter will pay dividends for its Watchman business.
Original Image Link
Source:www.msn.com


Posted: 2025-11-14 10:28:21

Get Full News Story On Bing Science News Network



Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.



More News From This Category
Scientific News: The next AI revolution could start with world models
Sat, 17 Jan 2026 14:07:16 +0000
Why today’s AI systems struggle with consistency, and how emerging world models aim to give machines a steady grasp of space and time ...
Original Image Link
Source:www.scientificamerican.com

Read More ...


Scientific News: A big acquisition decades ago almost broke Boston Scientific. Its CEO says this time is different.
Sat, 17 Jan 2026 14:07:16 +0000
Boston Scientific’s last mega-deal didn’t go so well. The medtech company with a large Minnesota presence acquired Arden Hills’ Guidant for $27 billion in 2006. This triggered years of legal ...
Original Image Link
Source:www.msn.com

Read More ...


Scientific News: Penumbra stock jumps. It’s being bought by Boston Scientific for $14.5 billion
Sat, 17 Jan 2026 08:07:13 +0000
Penumbra shares soared 12% to $351.46 on Thursday. Boston Scientific stock slumped 4.1%, making it one of the worst performers in the S&P 500. Boston Scientific was a Barron’s stock pick in October.
Original Image Link
Source:www.msn.com

Read More ...


Scientific News: Boston Scientific is buying Penumbra for $14.5 billion to get into the business of removing blood clots
Sat, 17 Jan 2026 05:07:15 +0000
Boston Scientific is spending $14.5 billion in cash and stock to buy Penumbra, another medical-device maker that makes products used in minimally invasive procedures to treat conditions such as blood ...
Original Image Link
Source:www.msn.com

Read More ...


Scientific News: Boston Scientific to buy Penumbra in $14.5 billion deal
Fri, 16 Jan 2026 05:07:14 +0000
Boston Scientific said on Thursday it will buy Penumbra in a deal valued at about $14.5 billion to expand its vascular pipeline. The deal values Penumbra at $374 per share, a premium of about 19.3% to ...
Original Image Link
Source:www.msn.com

Read More ...


Related Bing News Results
Scientists reverse Alzheimer’s in mice and restore memory
Wed, 24 Dec 2025 11:07:00 GMT
Alzheimer’s has long been considered irreversible, but new research challenges that assumption. Scientists discovered that severe drops in the brain’s energy supply help drive the disease—and ...


















Blow Us A Whistle


Related Product Search/Búsqueda de productos relacionados

Amazon Logo